Smith Kevin Raymond Merrill 4
4 · Inogen Inc · Filed Dec 2, 2025
Insider Transaction Report
Form 4
Inogen IncINGN
Smith Kevin Raymond Merrill
DirectorCEO and President
Transactions
- Exercise/Conversion
Common Stock
2025-12-01+28,334→ 100,108 total - Tax Payment
Common Stock
2025-12-01$6.95/sh−13,817$96,028→ 86,291 total - Exercise/Conversion
Restricted Stock Unit
2025-12-01−28,334→ 28,333 total→ Common Stock (28,334 underlying)
Footnotes (3)
- [F1]The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2025.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
- [F3]Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.